PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-36.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-28.71%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
41.46%
EBIT growth 1.25-1.5x 0354.HK's 32.56%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
36.37%
Operating income growth at 50-75% of 0354.HK's 57.51%. Martin Whitman would doubt the firm’s ability to compete efficiently.
33.37%
Positive net income growth while 0354.HK is negative. John Neff might see a big relative performance advantage.
34.60%
Positive EPS growth while 0354.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
34.60%
Positive diluted EPS growth while 0354.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-35.14%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-34.72%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-95.52%
Negative 10Y revenue/share CAGR while 0354.HK stands at 185.64%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-87.79%
Negative 5Y CAGR while 0354.HK stands at 34.07%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-53.53%
Negative 3Y CAGR while 0354.HK stands at 2.32%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-152.98%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
63.76%
Positive OCF/share growth while 0354.HK is negative. John Neff might see a comparative advantage in operational cash viability.
-0.65%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-298.63%
Negative 10Y net income/share CAGR while 0354.HK is at 97.02%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-439.52%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-39.06%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-46.65%
Negative equity/share CAGR over 10 years while 0354.HK stands at 231.55%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-47.97%
Negative 5Y equity/share growth while 0354.HK is at 66.58%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-45.59%
Negative 3Y equity/share growth while 0354.HK is at 31.28%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 0354.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 0354.HK stands at 271.19%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.45%
Negative asset growth while 0354.HK invests at 0.82%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.52%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-20.31%
We’re deleveraging while 0354.HK stands at 19.89%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-69.33%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-29.69%
We cut SG&A while 0354.HK invests at 128.30%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.